Cargando…
(18)F-FDG and (11)C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
(11)C-methionine ((11)C-MET) is a new positron emission tomography (PET) tracer for the assessment of disease activity in multiple myeloma (MM) patients, with preliminary data suggesting higher sensitivity and specificity than (18)F-fluorodeoxyglucose ((18)F-FDG). However, the value of tumor burden...
Autores principales: | Morales-Lozano, Maria I, Viering, Oliver, Samnick, Samuel, Rodriguez-Otero, Paula, Buck, Andreas K, Marcos-Jubilar, Maria, Rasche, Leo, Prieto, Elena, Kortüm, K Martin, San-Miguel, Jesus, Garcia-Velloso, Maria J., Lapa, Constantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226577/ https://www.ncbi.nlm.nih.gov/pubmed/32340251 http://dx.doi.org/10.3390/cancers12041042 |
Ejemplares similares
-
(11)C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
por: Lapa, Constantin, et al.
Publicado: (2017) -
(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
por: Morales-Lozano, Maria I., et al.
Publicado: (2022) -
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
por: Zhou, Xiang, et al.
Publicado: (2020) -
(11)C-Methionine-PET: A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
por: Lückerath, Katharina, et al.
Publicado: (2015) -
(11)C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement
por: Lapa, Constantin, et al.
Publicado: (2016)